The Procurement of a Biomark X9 Microfluidics System
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- Points of contact
-
- Cber Acquisition Liaison cbveracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for the procurement of a Biomark X9 Microfluidics System. The solicitation is expected to be released on May 1, 2026, with an anticipated award date of September 1, 2026. This procurement falls under the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers NAICS category and does not utilize any set-aside provisions.
The estimated award value for this contract opportunity ranges from $25,000 to $250,000. Interested vendors should direct inquiries to the FDA's Center for Biologics Evaluation and Research (CBER) Acquisitions team via email at cbveracquisitions@fda.hhs.gov. No set-aside restrictions apply to this procurement, allowing all eligible contractors to compete for this opportunity.
Forecast text
The Procurement of a Biomark X9 Microfluidics System
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast